HR 5541, the Every Kid Outdoors Reauthorization Act, expands eligibility for the program to include fifth graders (ages 10-11) and home-schooled learners in that age range, replacing the previous requirement for 10-year-olds. The bill authorizes $25 million annually for the National Park Service to support program operations, promote the initiative to schools and families, provide transportation assistance to financially needy schools and organizations, and conduct targeted outreach to underserved communities and children with disabilities. This reauthorization directly affects fifth-grade students and home-schooled learners aged 10-11, as well as schools and youth organizations participating in the program. The key change is broadening the age group served while maintaining the program's funding structure for operational support and equitable access.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
HCONRES 58 is a symbolic congressional resolution denouncing socialism in all its forms. It does not create new laws or affect any policies, as it is a non-binding statement of opinion. The resolution cites historical events and quotes from Founding Fathers to argue that socialism leads to authoritarianism and economic harm, referencing examples like the Soviet Union and Venezuela. It formally "denounces" socialism and opposes implementing socialist policies in the U.S., but has no legal effect on citizens or government actions. This is a procedural resolution, not a policy measure.
S 3284, the Streamline Transit Projects Act, allows large urban transit agencies (with populations over 200,000) that prove capacity to handle environmental reviews for certain transit projects. Eligible agencies would assume responsibility for determining which projects qualify as "categorical exclusions" (projects not requiring full environmental impact studies), replacing federal oversight for these specific activities. Agencies must follow public disclosure rules, sign agreements with the Transportation Secretary, and become legally liable for compliance, while the federal government monitors performance and can terminate agreements for poor execution. This bill directly affects major transit authorities in large cities, shifting a key federal review process to local agencies.
HR 6336, the Fair Allocation of Interstate Rates Act, prohibits electric transmission providers serving customers in multiple states from charging out-of-state consumers for facilities built to implement a state's energy policies, unless that state consents. The bill directly affects multistate utilities and their customers, requiring that costs for "covered transmission facilities" (those built to implement a state's energy policy) be allocated only to residents of the state that enacted the policy. It creates a legal presumption that only residents of the implementing state are responsible for these costs, with an exception allowing out-of-state charges if the customer's state explicitly agrees. The Federal Energy Regulatory Commission must issue implementing rules within six months of the bill's enactment.
HR 5652, the Wildfire Recovery Act, increases federal reimbursement for wildfire response by setting a minimum 75% federal cost share under Section 420 of the Stafford Act, directly benefiting states, local governments, and Tribal governments that deploy firefighting resources. It requires FEMA to develop rules within three years to determine when the federal share could exceed 75% based on a state's financial impact from wildfires. The bill also updates FEMA policy to allow reimbursement for predeployment of fire assets (like crews or equipment) before a fire occurs. These changes aim to provide more predictable and timely federal support for wildfire recovery efforts.
The FRESHER Act of 2025 requires the Secretary of the Interior to study stormwater runoff impacts from oil, gas, and mining operations on groundwater and aquifers. It mandates a specific analysis of measurable contamination, groundwater resources, and aquifer susceptibility to contamination in affected areas. The study must be completed within one year of the bill's enactment, with results reported to Congress. This bill directly affects oil, gas, and mining operations by establishing new federal study requirements for their stormwater runoff.
This bill requires Medicaid programs to cover lung cancer biomarker testing for eligible enrollees, beginning January 1, 2027. It directly affects Medicaid recipients diagnosed with lung cancer who need these specific tests to guide treatment decisions. The key provision adds "lung cancer biomarker testing" as a mandatory benefit under Medicaid, amending the Social Security Act to require coverage for this diagnostic service. The change applies to all state Medicaid programs participating in the federal program, ensuring standardized access to this testing method. Coverage starts in 2027, with no additional state cost-sharing required for this specific test.
This bill establishes a Lung Cancer Task Force within the National Institutes of Health (NIH) to examine key issues in lung cancer research and care. The task force, appointed by the NIH Director, will specifically study differences in research funding and patient access compared to other diseases, assess if federal funding matches lung cancer's health impact, and review current lung cancer screening practices in the U.S. Within 180 days of the bill's passage, the task force must submit a report to Congress with its findings and recommendations for increasing federal funding for lung cancer research. The bill directly affects federal health agencies (NIH and CDC) and aims to inform future policy decisions based on the task force's analysis.
This bill requires Medicare to cover lung cancer biomarker testing for beneficiaries diagnosed with lung cancer, starting January 1, 2027. It defines the testing as procedures analyzing tissue, blood, or bodily fluids to identify specific biomarkers (like genes or proteins) for treatment planning. Medicare will pay 100% of reasonable charges for these tests, removing out-of-pocket costs for patients. The policy directly affects Medicare patients with lung cancer who need this specialized testing to guide personalized treatment options.
HRES 911 is a symbolic resolution recognizing National Native American Heritage Month (November 1-30) and Native American Heritage Day, as established by prior law. It urges the public to observe these occasions through programs that celebrate Native American cultures, heritages, and contributions to U.S. history, including fields like agriculture, medicine, military service, and language. The resolution does not create new legal requirements but formally acknowledges the ongoing significance of Native American communities and their historical impact. It aligns with existing congressional support for Tribal self-governance and honors the contributions of Native Americans as documented in the 2009 Native American Heritage Day Act.
This bill increases disability compensation for veterans with service-connected disabilities and dependency and indemnity compensation for surviving spouses and children of deceased veterans, effective December 1, 2025. The increases will match the percentage rise in Social Security benefits for that year, as determined under the Social Security Act. It directly affects veterans receiving disability payments and surviving family members eligible for survivor benefits under current law. The adjustment ensures these benefits keep pace with inflation, as required by the Social Security cost-of-living adjustment formula.
